全文获取类型
收费全文 | 2374423篇 |
免费 | 176624篇 |
国内免费 | 3467篇 |
专业分类
耳鼻咽喉 | 32323篇 |
儿科学 | 76269篇 |
妇产科学 | 62984篇 |
基础医学 | 351908篇 |
口腔科学 | 64492篇 |
临床医学 | 213178篇 |
内科学 | 463989篇 |
皮肤病学 | 52496篇 |
神经病学 | 187158篇 |
特种医学 | 89113篇 |
外国民族医学 | 489篇 |
外科学 | 358814篇 |
综合类 | 47646篇 |
现状与发展 | 12篇 |
一般理论 | 849篇 |
预防医学 | 183583篇 |
眼科学 | 54894篇 |
药学 | 177247篇 |
11篇 | |
中国医学 | 4610篇 |
肿瘤学 | 132449篇 |
出版年
2021年 | 19496篇 |
2019年 | 19920篇 |
2018年 | 27546篇 |
2017年 | 20808篇 |
2016年 | 23234篇 |
2015年 | 26166篇 |
2014年 | 36765篇 |
2013年 | 54804篇 |
2012年 | 75937篇 |
2011年 | 80806篇 |
2010年 | 47867篇 |
2009年 | 45303篇 |
2008年 | 75828篇 |
2007年 | 80694篇 |
2006年 | 81533篇 |
2005年 | 79101篇 |
2004年 | 75604篇 |
2003年 | 72948篇 |
2002年 | 70558篇 |
2001年 | 109722篇 |
2000年 | 112473篇 |
1999年 | 94412篇 |
1998年 | 27348篇 |
1997年 | 23965篇 |
1996年 | 24322篇 |
1995年 | 22967篇 |
1994年 | 21117篇 |
1993年 | 19917篇 |
1992年 | 72634篇 |
1991年 | 70633篇 |
1990年 | 68967篇 |
1989年 | 66221篇 |
1988年 | 60872篇 |
1987年 | 59618篇 |
1986年 | 55698篇 |
1985年 | 53484篇 |
1984年 | 39617篇 |
1983年 | 33669篇 |
1982年 | 19989篇 |
1979年 | 36129篇 |
1978年 | 25830篇 |
1977年 | 21364篇 |
1976年 | 20436篇 |
1975年 | 21943篇 |
1974年 | 26329篇 |
1973年 | 24930篇 |
1972年 | 23352篇 |
1971年 | 22161篇 |
1970年 | 20366篇 |
1969年 | 19437篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
24.
Troppmair Teresa Egger J. Krösbacher A. Zanvettor A. Schinnerl A. Neumayr A. Baubin M. 《Der Anaesthesist》2022,71(4):272-280
Die Anaesthesiologie - Die Qualität eines Rettungssystems zeichnet sich auch durch den effizienten Einsatz seiner personellen und Fahrzeugressourcen aus. So können im berechtigten Fall... 相似文献
25.
26.
Keiko Goto Yutaka Fujiwara Takeshi Isobe Naoko Chayahara Naomi Kiyota Toru Mukohara Yukari Tsubata Takamasa Hotta Kenji Tamura Noboru Yamamoto Hironobu Minami 《Cancer science》2019,110(6):1987-1994
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oteracil potassium, and to review the recommended dose modification of S‐1 in patients with renal impairment. We classified patients receiving S‐1 into 4 groups according to their renal function, as measured using the Japanese estimated glomerular filtration rate (eGFR) equation. The daily S‐1 dose was adjusted based on the patient's eGFR and body surface area. Blood samples were collected for pharmacokinetic analysis. A total of 33 patients were enrolled and classified into 4 groups as follows: 10 patients in cohort 1 (eGFR ≥ 80 mL/min/1.73 m2), 10 patients in cohort 2 (eGFR = 50‐79 mL/min/1.73 m2), 10 patients in cohort 3 (eGFR = 30‐49 mL/min/1.73 m2), and 3 patients in cohort 4 (eGFR < 30 mL/min/1.73 m2). Those in cohorts 3 and 4 treated with an adjusted dose of S‐1 showed a similar area under the curve for 5‐fluorouracil (941.9 ± 275.6 and 1043.5 ± 224.8 ng/mL, respectively) compared with cohort 2 (1034.9 ± 414.3 ng/mL). Notably, while there was a statistically significant difference between cohort 1 (689.6 ± 208.8 ng/mL) and 2 (P = 0.0474) treated with an equal dose of S‐1, there was no significant difference observed in the toxicity profiles of the cohorts. In conclusion, dose adjustment of S‐1 in patients with impaired renal function using eGFR is appropriate and safe. 相似文献
27.
28.
29.
Xiying Fan Glen A. Bjerke Kent Riemondy Li Wang Rui Yi 《Molecular carcinogenesis》2019,58(12):2241-2253
MicroRNAs (miRNAs) play important roles in prostate cancer development. However, it remains unclear how individual miRNAs contribute to the initiation and progression of prostate cancer. Here we show that a basal layer‐enriched miRNA is required for prostate tumorigenesis. We identify miR‐205 as the most highly expressed miRNA and enriched in the basal cells of the prostate. Although miR‐205 is not required for normal prostate development and homeostasis, genetic deletion of miR‐205 in a Pten null tumor model significantly compromises tumor progression and does not promote metastasis. In Pten null basal cells, loss of miR‐205 attenuates pAkt levels and promotes cellular senescence. Furthermore, although overexpression of miR‐205 in prostate cancer cells with luminal phenotypes inhibits cell growth in both human and mouse, miR‐205 has a minimal effect on the growth of a normal human prostate cell line. Taken together, we have provided genetic evidence for a requirement of miR‐205 in the progression of Pten null‐induced prostate cancer. 相似文献
30.
M.-A. Fauroux A. Germa P. Tramini C. Nabet 《Revue d'épidémiologie et de santé publique》2019,67(4):223-231
BackgroundThe aim of this study was to estimate the prevalence of dental prosthetic treatment and to investigate the demographic, social, economic and medical factors associated with the use of fixed and removable dentures in a representative sample of adults living in France.MethodsThe data were obtained from the 2002–2003 Decennial Health Survey, a cross-sectional study of a representative sample of the population living in France, which included 29,679 adults. Information was collected by interview. The variables collected were fixed denture, removable denture, age, gender, number of children, area of residence, nationality, educational attainment, family social status, employment status, annual household income per capita, supplementary insurance, chronic disease, eyesight problems/glasses, hearing problems/hearing aids. Multinomial logistic regression models were used to study the relationship between prosthetic treatment and demographic, socioeconomic and medical characteristics unadjusted, adjusted for age and adjusted for all the characteristics.ResultsThe prevalence of prosthetic treatment was 34.6% (95% confidence interval (CI): [34.1; 35.2]) for fixed prosthetic dentures and 13.8% (95% CI: [13.4; 14.2]) for removable prosthetic dentures. We showed a gradient between educational attainment and removable dentures; the odds ratio adjusted for all the variables (aOR) associated with no or primary education compared to post-secondary education was 2.56; 95% CI: [2.09; 3.13]. When annual household income per capita was low, subjects were less likely to report fixed dentures (aOR = 0.68; 95% CI: [0.62; 0.75]) than those with high annual household income per capita. Individuals without insurance less often reported fixed dentures than those with private insurance. Those reporting chronic disease were less likely to report fixed dentures (aOR = 0.87; 95% CI: [0.79; 0.95]) but more likely to report removable dentures (aOR = 1.29; 95% CI: [1.17; 1.43]) than those without chronic disease.ConclusionThis study reveals social, economic and medical inequalities in fixed and removable prosthetic treatment among adults in France. 相似文献